Oncopharmpod
Lenvatinib vs. Sorafenib (HCC)
- Author: Vários
- Narrator: Vários
- Publisher: Podcast
- Duration: 0:11:52
- More information
Informações:
Synopsis
Reviewing the REFLECT (https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(18)30207-1/fulltext) study and its take-home points on selecting an agent for advanced HCC.